Trump's pressure on the media is mounting, with Kimmel sidelined 'indefinitely'

Kimmel's hiatus is drawing comparisons to CBS' cancellation of "The Late Show With Stephen Colbert" and raising questions about the protection of free speech....

American Express unveils refreshed Platinum card with $895 annual fee, upping the ante in luxury cards

American Express' move highlights an arms race of sorts when it comes to catering to wealthy consumers. JPMorgan and Citi released updated or new cards recently....

Olive Garden owner Darden Restaurants disappoints on earnings but hikes sales outlook

Olive Garden owner Darden Restaurants missed fiscal 2026 first-quarter earnings estimates but raised its fiscal 2026 forecast for revenue growth....

Oracle's Larry Ellison made his $365 billion fortune by breaking every rule of wealth management

Larry Ellison's fortune is built on mountains of leverage and risk, allowing him to borrow against his shares and raise cash without giving up control. ...

Covid shot access, coverage at stake as RFK Jr.'s hand-picked vaccine panel convenes 

Some experts warn that weakening recommendations for Covid vaccines and other shots could make it harder for some people to access jabs and have them covered. ...

Hyundai outlines ambitious U.S. growth plans weeks after ICE immigration raid at battery plant

Hyundai is increasing its revenue expectations for 2025, despite ongoing U.S. tariffs causing the automaker to lower its expected operating profit for the year....

Spirit CEO says struggling airline will slash flights, braces employees for more job cuts

Spirit is slashing its November schedule by 25% and is bracing staff for more job cuts....

Cracker Barrel stock falls as company reports mixed earnings after rebrand controversy

Cracker Barrel reported fourth-quarter earnings after the bell on Wednesday....

'That's cute': Frontier CEO fires back at United CEO declaring discount airline model dead

Frontier Airlines CEO fired back at United's CEO for saying the discount airline model is dead in the United States....

Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped patients lose more weight. ...